Background: Cardiovascular disease is the most frequent cause of morbidity and mortality throughout the world. The aim of the study was to determine assessment of risk factors and impact of patient counseling in health-related quality of life of the patient.Method: This was a prospective observational study conducted in the department of cardiology. A suitably designed standard SF-36 questionnaire was given to all patients enrolled in the study before and after counseling. All information relevant to the study were collected in suitably designed proforma from case records and discussions conducted with the patients and bystanders during ward rounds. Proper counseling was given to patients and bystanders and the score was analyzed using SAS descriptive analysis.Result: The most common risk factors encountered in the study are diabetes mellitus, hypertension, dyslipidemia, irregular exercise, smoking, alcoholism, obesity and family history. The health-related quality of life of the patients were assessed, a total of 67 patients QOL was improved after counseling and 27 patients with no improvement. We found that patient counseling was effective for majority of patients.Conclusions: We can conclude that the role of clinical pharmacist has a significant role in improving the health-related quality of life of patients through proper counseling. And more than half of the patients have a modifiable risk factor which can be managed through lifestyle modifications.

Coronary artery disease is a condition in which there is an inadequate supply of blood and oxygen to a portion of the myocardium. It is the major cause responsible for mortality more in younger age group than in elderly. Since it is an emergency condition where usage of many drugs during its management is common. The study of drug utilization is a component of a medical audit and periodic evaluation should be done to enable suitable modifications in the prescription of drugs and maximize the therapeutic benefit and minimize the adverse effects. When new drugs are used additional information on safety and efficacy may be generated. In this review most of the prescription contain anti-platelet drugs, ACE inhibitors/ ARBs, Statins, Beta-blockers, Nitrates, Calcium channel blockers and Diuretics.

No abstract

No abstract

Background: The aim of the study is to assess the proportion of types of coronary artery diseases and to analyze the trends of drug prescribing in coronary artery disease (CAD) by checking the compliance with the standard guidelines provided by the American College of Cardiology Foundation / American Heart Association (ACCF/AHA).Methods: A prospective observational study was conducted in the department of Cardiology for a period of 6 months. A total of 94 patients with varied categories of CAD were screened and analyzed. Study related data was collected from case records and by a structured interview. Data analysis was done by analyzing the prescribing trends of drug and assessing the proportion of CAD.Results: The current study found that most of the patients were of the age group of 61-70 years. The proportion of Non-ST segment elevation myocardial infarction (NSTEMI) was remarkably higher in patients with CAD (55.3%) followed by ST-elevated myocardial infarction (STEMI) (39.4%) and Unstable angina (5.3%). Chi square test shows that prescription of Antiplatelets were apparent in all the prescriptions (100%), followed by Statins (Atorvastatin 98.9%), Antihypertensives (94.7%), Anticoagulants (90.4%), Nitrates (76.6%), Antidiabetics (75.5%) and Potassium channel opener (Nicorandil 36.2%). By analyzing the prescription, it was observed that most of the drugs were prescribed rationally according to the standard treatment guidelines (ACCF/AHA).Conclusions: This study provides an overall insight of proportion of CAD and prescribing pattern in patients with CAD which reveals the rational prescribing of drugs in accordance with the standard guidelines.